CASP3 and idiopathic pulmonary fibrosis: IPF-derived primary lung fibroblasts had a 1.6-fold increase in caspase-3/7 activity in response to treatment with ABT-263 (1 μM) compared with healthy fibroblasts (Figure 3A).